ALL Adult Consortium Trial: Adult ALL Trial

NCT00476190 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Doxorubicin
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Vincristine
DRUG: Cyclophosphamide
DRUG: Methylprednisone
DRUG: Hydrocortisone Sodium Succinate
DRUG: Dexamethasone
DRUG: 6-MP
DRUG: PEG-Asparaginase
DRUG: Imatinib
DRUG: Etoposide
PROCEDURE: Radiation Therapy
DRUG: E. coli Asparaginase

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]